(Q28575182)

31 January 2017

title

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics (English)

1 reference

lysergic acid diethylamide

31 January 2017

0 references

1 reference

P. Seeman

1

1 reference

31 January 2017

F. Ko

series ordinal

2

1 reference

31 January 2017

T. Tallerico

series ordinal

3

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

31 January 2017

1 reference

31 January 2017

volume

10

1 reference

31 January 2017

issue

9

1 reference

31 January 2017

page(s)

877–883

1 reference

Dopamine receptors and the dopamine hypothesis of schizophrenia

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Effects of phencyclidine on rat prolactin, dopamine receptor and locomotor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Comment on "Diverse psychotomimetics act through a common signaling pathway".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Link between dopamine D1 and D2 receptors in rat and human striatal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

D1 and NMDA receptors hook up: expanding on an emerging theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Lysergic acid diethylamide: Evidence for stimulation of pituitary dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Phencyclidine-induced inhibition of rat prolactin secretion: increased portal blood dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Effect of ionotropic and metabotropic glutamate agonists and D-aspartate on prolactin release from anterior pituitary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Direct stimulation of pituitary prolactin release by glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Acute Ketamine Intoxication Treated by Haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

The human dopamine D2(Longer) receptor has a high-affinity state and inhibits adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

7 January 2021

Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

7 January 2021

Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

7 January 2021

Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001682

7 January 2021